Disciplined Investments’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15
Closed -$111 1075
2023
Q2
$111 Hold
15
﹤0.01% 1589
2023
Q1
$104 Buy
+15
New +$138 ﹤0.01% 1572
2022
Q4
Sell
-15
Closed 1672
2022
Q3
$0 Sell
15
-2
-12% -$87 ﹤0.01% 1486
2022
Q2
$1K Hold
17
﹤0.01% 1036
2022
Q1
$1K Buy
17
+2
+13% +$178 ﹤0.01% 1100
2021
Q4
$2K Hold
15
﹤0.01% 450
2021
Q3
$3K Hold
15
﹤0.01% 377
2021
Q2
$3K Hold
15
﹤0.01% 366
2021
Q1
$3K Buy
+15
New +$2.99K ﹤0.01% 317

Other funds holding NVAX

Disciplined Investments's NVAX Position: Q3 2023 in Review

Disciplined Investments sold out of Novavax (NVAX) in Q3 2023, closing a stake of 15 shares — an estimated $111 sold.

Disciplined Investments first reported a position in NVAX in Q1 2021 and held it in 9 quarters. The position peaked at $3K in Q3 2021. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • Disciplined Investments reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 15 Novavax shares in Q3 2023, an estimated $111.
  • Disciplined Investments first reported a position in Novavax in Q1 2021 and held it in 9 quarters.
  • Disciplined Investments's Novavax position peaked at $3K in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.